Evidence of 18F-FCH uptake in human T98G glioblastoma cells

Federica Eleonora Buroni, Francesca Pasi, Marco Giovanni Persico, Lorenzo Lodola, Carlo Aprile, Rosanna Nano

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim: Tumor and chemo/radiotherapy-damaged brain tissues are hardly distinguishable by conventional morphological imaging. 18F-FCH was compared against 18F-FDG in the T98G glioblastoma cell line with regard to their radiopharmaceutical uptake, in order to test its diagnostic power on brain tumor lesions. Materials and Methods: Equimolar amounts of 18F-FCH and 18F-FDG were added to human glioblastoma T98G cells and human dermal fibroblasts for 20, 40, 60, 90 and 120 min of incubation. Radiopharmaceutical uptake was expressed as a percentage of the administered dose. Cold choline was used for binding competition experiments. Results: In T98G cells 18F-FCH was taken-up in higher amounts than 18F-FDG after 60 min. In fibroblasts, uptake was lower than 1% for both radiopharmaceuticals. Cold choline reduced the uptake of FCH to 1% similarly to fibroblasts. Conclusion: Our results prove the efficacy of 18F-FCH as a promising tracer, better than 18F-FDG in establishing the tumor-tobackground ratio in brain tumors.

Original languageEnglish
Pages (from-to)6439-6444
Number of pages6
JournalAnticancer Research
Volume35
Issue number12
Publication statusPublished - Dec 1 2015

Fingerprint

Fluorodeoxyglucose F18
Glioblastoma
Radiopharmaceuticals
Fibroblasts
Choline
Brain Neoplasms
Routine Diagnostic Tests
Neoplasms
Radiotherapy
Cell Line
Skin
fluorocholine
Brain

Keywords

  • F-fluorocholine
  • F-fluorodeoxyglucose
  • Glioma
  • Radiation injury
  • T98G human cells

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Buroni, F. E., Pasi, F., Persico, M. G., Lodola, L., Aprile, C., & Nano, R. (2015). Evidence of 18F-FCH uptake in human T98G glioblastoma cells. Anticancer Research, 35(12), 6439-6444.

Evidence of 18F-FCH uptake in human T98G glioblastoma cells. / Buroni, Federica Eleonora; Pasi, Francesca; Persico, Marco Giovanni; Lodola, Lorenzo; Aprile, Carlo; Nano, Rosanna.

In: Anticancer Research, Vol. 35, No. 12, 01.12.2015, p. 6439-6444.

Research output: Contribution to journalArticle

Buroni, FE, Pasi, F, Persico, MG, Lodola, L, Aprile, C & Nano, R 2015, 'Evidence of 18F-FCH uptake in human T98G glioblastoma cells', Anticancer Research, vol. 35, no. 12, pp. 6439-6444.
Buroni FE, Pasi F, Persico MG, Lodola L, Aprile C, Nano R. Evidence of 18F-FCH uptake in human T98G glioblastoma cells. Anticancer Research. 2015 Dec 1;35(12):6439-6444.
Buroni, Federica Eleonora ; Pasi, Francesca ; Persico, Marco Giovanni ; Lodola, Lorenzo ; Aprile, Carlo ; Nano, Rosanna. / Evidence of 18F-FCH uptake in human T98G glioblastoma cells. In: Anticancer Research. 2015 ; Vol. 35, No. 12. pp. 6439-6444.
@article{9d10bc0d91664779890b828c87b8be6f,
title = "Evidence of 18F-FCH uptake in human T98G glioblastoma cells",
abstract = "Aim: Tumor and chemo/radiotherapy-damaged brain tissues are hardly distinguishable by conventional morphological imaging. 18F-FCH was compared against 18F-FDG in the T98G glioblastoma cell line with regard to their radiopharmaceutical uptake, in order to test its diagnostic power on brain tumor lesions. Materials and Methods: Equimolar amounts of 18F-FCH and 18F-FDG were added to human glioblastoma T98G cells and human dermal fibroblasts for 20, 40, 60, 90 and 120 min of incubation. Radiopharmaceutical uptake was expressed as a percentage of the administered dose. Cold choline was used for binding competition experiments. Results: In T98G cells 18F-FCH was taken-up in higher amounts than 18F-FDG after 60 min. In fibroblasts, uptake was lower than 1{\%} for both radiopharmaceuticals. Cold choline reduced the uptake of FCH to 1{\%} similarly to fibroblasts. Conclusion: Our results prove the efficacy of 18F-FCH as a promising tracer, better than 18F-FDG in establishing the tumor-tobackground ratio in brain tumors.",
keywords = "F-fluorocholine, F-fluorodeoxyglucose, Glioma, Radiation injury, T98G human cells",
author = "Buroni, {Federica Eleonora} and Francesca Pasi and Persico, {Marco Giovanni} and Lorenzo Lodola and Carlo Aprile and Rosanna Nano",
year = "2015",
month = "12",
day = "1",
language = "English",
volume = "35",
pages = "6439--6444",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "12",

}

TY - JOUR

T1 - Evidence of 18F-FCH uptake in human T98G glioblastoma cells

AU - Buroni, Federica Eleonora

AU - Pasi, Francesca

AU - Persico, Marco Giovanni

AU - Lodola, Lorenzo

AU - Aprile, Carlo

AU - Nano, Rosanna

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Aim: Tumor and chemo/radiotherapy-damaged brain tissues are hardly distinguishable by conventional morphological imaging. 18F-FCH was compared against 18F-FDG in the T98G glioblastoma cell line with regard to their radiopharmaceutical uptake, in order to test its diagnostic power on brain tumor lesions. Materials and Methods: Equimolar amounts of 18F-FCH and 18F-FDG were added to human glioblastoma T98G cells and human dermal fibroblasts for 20, 40, 60, 90 and 120 min of incubation. Radiopharmaceutical uptake was expressed as a percentage of the administered dose. Cold choline was used for binding competition experiments. Results: In T98G cells 18F-FCH was taken-up in higher amounts than 18F-FDG after 60 min. In fibroblasts, uptake was lower than 1% for both radiopharmaceuticals. Cold choline reduced the uptake of FCH to 1% similarly to fibroblasts. Conclusion: Our results prove the efficacy of 18F-FCH as a promising tracer, better than 18F-FDG in establishing the tumor-tobackground ratio in brain tumors.

AB - Aim: Tumor and chemo/radiotherapy-damaged brain tissues are hardly distinguishable by conventional morphological imaging. 18F-FCH was compared against 18F-FDG in the T98G glioblastoma cell line with regard to their radiopharmaceutical uptake, in order to test its diagnostic power on brain tumor lesions. Materials and Methods: Equimolar amounts of 18F-FCH and 18F-FDG were added to human glioblastoma T98G cells and human dermal fibroblasts for 20, 40, 60, 90 and 120 min of incubation. Radiopharmaceutical uptake was expressed as a percentage of the administered dose. Cold choline was used for binding competition experiments. Results: In T98G cells 18F-FCH was taken-up in higher amounts than 18F-FDG after 60 min. In fibroblasts, uptake was lower than 1% for both radiopharmaceuticals. Cold choline reduced the uptake of FCH to 1% similarly to fibroblasts. Conclusion: Our results prove the efficacy of 18F-FCH as a promising tracer, better than 18F-FDG in establishing the tumor-tobackground ratio in brain tumors.

KW - F-fluorocholine

KW - F-fluorodeoxyglucose

KW - Glioma

KW - Radiation injury

KW - T98G human cells

UR - http://www.scopus.com/inward/record.url?scp=84949466453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949466453&partnerID=8YFLogxK

M3 - Article

C2 - 26637854

AN - SCOPUS:84949466453

VL - 35

SP - 6439

EP - 6444

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 12

ER -